XML 45 R36.htm IDEA: XBRL DOCUMENT v3.20.1
Equity Incentive Plan (Tables)
9 Months Ended
Mar. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of assumptions for options granted
   

As of March 31,

2020

 
       
Volatility     100.0 %
Equivalent term (years)     10.00  
Risk-free interest rate     1.82 %
Dividend yield     0.00 %
Schedule of stock option activity
     Number of Options      Weighted Average Exercise Price      Weighted Average Remaining Contractual Life in Years  
Outstanding June 30, 2019   $ 1,607     $ 325.73       6.13  
Granted     339,500       0.98       10.00  
Exercised     (2,500 )     0.97        
Expired     (170 )     328.00        
Outstanding March 31, 2020     338,437       2.36       9.62  
Exercisable at March 31, 2020     11,437       41.74       9.30  
Schedule of restricted stock activity
     Number of Shares      Weighted Average Grant Date Fair Value      Weighted Average Remaining Contractual Life in Years  
                   
 Unvested at June 30, 2019     2,346,214     $ 1.83       9.1  
 Granted     1,067,912       0.73       1.7  
 Vested                  
 Forfeited     (69,900 )     2.03        
 Unvested at March 31, 2020     3,344,226     $ 1.47       7.2  
Schedule of stock-based compensation expense
     Three Months Ended March 31,      Nine Months Ended March 31,  
 Selling, general and administrative:   2020     2019     2020     2019  
Stock options   $ 7,000     $ 15,000     $ 14,000     $ 122,000  
Restricted stock     257,000       362,000       577,000       601,000  
 Total stock-based compensation expense   $ 264,000     $ 377,000     $ 591,000     $ 723,000